203 related articles for article (PubMed ID: 25569461)
1. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles.
Chen J; Ormes JD; Higgins JD; Taylor LS
Mol Pharm; 2015 Feb; 12(2):533-41. PubMed ID: 25569461
[TBL] [Abstract][Full Text] [Related]
2. Leaching of Lopinavir Amorphous Solid Dispersions in Acidic Media.
Li N; Ormes JD; Taylor LS
Pharm Res; 2016 Jul; 33(7):1723-35. PubMed ID: 27026009
[TBL] [Abstract][Full Text] [Related]
3. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
4. Impact of surfactants on the crystal growth of amorphous celecoxib.
Mosquera-Giraldo LI; Trasi NS; Taylor LS
Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
[TBL] [Abstract][Full Text] [Related]
5. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
Al-Obaidi H; Lawrence MJ; Buckton G
J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
[TBL] [Abstract][Full Text] [Related]
6. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
7. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
Rahman M; Arevalo F; Coelho A; Bilgili E
Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
[TBL] [Abstract][Full Text] [Related]
8. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
9. Impact of Surfactant and Surfactant-Polymer Interaction on Desupersaturation of Clotrimazole.
Zhang W; Hate SS; Russell DJ; Hou HH; Nagapudi K
J Pharm Sci; 2019 Oct; 108(10):3262-3271. PubMed ID: 31207217
[TBL] [Abstract][Full Text] [Related]
10. Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
Indulkar AS; Lou X; Zhang GGZ; Taylor LS
Pharm Res; 2022 Feb; 39(2):381-397. PubMed ID: 35169959
[TBL] [Abstract][Full Text] [Related]
11. Influence of polymer molecular weight on in vitro dissolution behavior and in vivo performance of celecoxib:PVP amorphous solid dispersions.
Knopp MM; Nguyen JH; Becker C; Francke NM; Jørgensen EB; Holm P; Holm R; Mu H; Rades T; Langguth P
Eur J Pharm Biopharm; 2016 Apr; 101():145-51. PubMed ID: 26899127
[TBL] [Abstract][Full Text] [Related]
12. Impact of surfactant selection and incorporation on in situ nanoparticle formation from amorphous solid dispersions.
Yen CW; Kuhn R; Hu C; Zhang W; Chiang PC; Chen JZ; Hau J; Estevez A; Nagapudi K; Leung DH
Int J Pharm; 2021 Sep; 607():120980. PubMed ID: 34371147
[TBL] [Abstract][Full Text] [Related]
13. Surface composition of spray-dried particles of bovine serum albumin/trehalose/surfactant.
Adler M; Unger M; Lee G
Pharm Res; 2000 Jul; 17(7):863-70. PubMed ID: 10990207
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of crystallization and growth of celecoxib nanoparticles formed from volatile microemulsions.
Margulis-Goshen K; Weitman M; Major DT; Magdassi S
J Pharm Sci; 2011 Oct; 100(10):4390-400. PubMed ID: 21630277
[TBL] [Abstract][Full Text] [Related]
15. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
16. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
Xie T; Taylor LS
J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
[TBL] [Abstract][Full Text] [Related]
17. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
18. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
19. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.
Yang R; Zhang GGZ; Zemlyanov DY; Purohit HS; Taylor LS
Pharm Res; 2023 Dec; 40(12):2817-2845. PubMed ID: 37052841
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions.
Deshpande TM; Shi H; Pietryka J; Hoag SW; Medek A
Mol Pharm; 2018 Mar; 15(3):962-974. PubMed ID: 29345955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
